Drug profile · INN
sulfadiazine sodium
SULFADIAZINE SODIUM
sulfadiazine sodium (SULFADIAZINE SODIUM) is a bacterial dihydropteroate synthase inhibitor. Route of administration: injection. Current US regulatory status: approved.
Drug details — sulfadiazine sodium
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
sulfadiazine sodium (SULFADIAZINE SODIUM) is a bacterial dihydropteroate synthase inhibitor. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial dihydropteroate synthase inhibitor
Primary target: Dihydropteroate synthase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is sulfadiazine sodium?
sulfadiazine sodium (SULFADIAZINE SODIUM) is a bacterial dihydropteroate synthase inhibitor. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for sulfadiazine sodium?
SULFADIAZINE SODIUM is a marketed brand name for sulfadiazine sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sulfadiazine sodium?
sulfadiazine sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.